Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market
This book discusses the implications of the 2009 EU Commission’s Pharmaceutical Sector Inquiry on originator’s opportunities to apply Intellectual Property related measures in defending against generic competition. It argues that on the one hand recent developments in EU competition law do indeed im...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Online |
| Мова: | Англійська |
| Опубліковано: |
Nomos Verlagsgesellschaft mbH & Co. KG
2021
|
| Предмети: | |
| Онлайн доступ: | 29431 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| _version_ | 1869522012905406464 |
|---|---|
| author | Philipp, Marc P. |
| author_browse | Philipp, Marc P. |
| author_facet | Philipp, Marc P. |
| author_sort | Philipp, Marc P. |
| collection | Directory of Open Access Books |
| description | This book discusses the implications of the 2009 EU Commission’s Pharmaceutical Sector Inquiry on originator’s opportunities to apply Intellectual Property related measures in defending against generic competition. It argues that on the one hand recent developments in EU competition law do indeed impose potential limitations on an originator’s ability to block or delay generic market entry. On the other hand, the book calls for a differentiated assessment of the rather broad allegations made by the sector inquiry. The book thereby presents and thoroughly analyzes six key issues identified by the EU Commission in the inquiry’s final report: Blocking/defensive patenting, patent thickets, patent-related disputes and litigation, follow-on innovation, authorized generic entries and patent settlement agreements as well as interventions into generic marketing authorization. The analysis aims at reducing legal uncertainty by providing a clearer picture of legal boundaries between legitimate and problematic conduct under Arts. 101 and 102 TFEU. The book also puts the sector inquiry’s findings into a forward-looking perspective by highlighting industry trends with the potential to transform traditional originator and generic business models. The author studied economics and law, has gained substantial expertise about strategy development as a consultant to the pharmaceutical industry and currently leads strategic research management at a large life sciences public research organization in Germany. |
| format | Online |
| id | doab-20.500.12854ir-50417 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Nomos Verlagsgesellschaft mbH & Co. KG |
| publisherStr | Nomos Verlagsgesellschaft mbH & Co. KG |
| record_format | ojs |
| spelling | doab-20.500.12854ir-504172023-12-20T16:24:33Z Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market Philipp, Marc P. K1-7720 Wettbewerbsrecht Handels- und Wirtschaftsrecht Kartellrecht bic Book Industry Communication::L Law This book discusses the implications of the 2009 EU Commission’s Pharmaceutical Sector Inquiry on originator’s opportunities to apply Intellectual Property related measures in defending against generic competition. It argues that on the one hand recent developments in EU competition law do indeed impose potential limitations on an originator’s ability to block or delay generic market entry. On the other hand, the book calls for a differentiated assessment of the rather broad allegations made by the sector inquiry. The book thereby presents and thoroughly analyzes six key issues identified by the EU Commission in the inquiry’s final report: Blocking/defensive patenting, patent thickets, patent-related disputes and litigation, follow-on innovation, authorized generic entries and patent settlement agreements as well as interventions into generic marketing authorization. The analysis aims at reducing legal uncertainty by providing a clearer picture of legal boundaries between legitimate and problematic conduct under Arts. 101 and 102 TFEU. The book also puts the sector inquiry’s findings into a forward-looking perspective by highlighting industry trends with the potential to transform traditional originator and generic business models. The author studied economics and law, has gained substantial expertise about strategy development as a consultant to the pharmaceutical industry and currently leads strategic research management at a large life sciences public research organization in Germany. 2021-02-11T16:26:17Z 2021-02-11T16:26:17Z 2018-11-05 12:58:39 2011 book 29431 9783845231037 https://directory.doabooks.org/handle/20.500.12854/50417 eng Munich Intellectual Property Law Center – MIPLC image/png Attribution 4.0 International https://www.nomos-elibrary.de/10.5771/9783845231037 Nomos Verlagsgesellschaft mbH & Co. KG http://dx.doi.org/10.5771/9783845231037 http://dx.doi.org/10.5771/9783845231037 20c8b06d-3b2b-4af2-acda-fbcfdfea5744 9783845231037 92 open access |
| spellingShingle | K1-7720 Wettbewerbsrecht Handels- und Wirtschaftsrecht Kartellrecht bic Book Industry Communication::L Law Philipp, Marc P. Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market |
| title | Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market |
| title_full | Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market |
| title_fullStr | Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market |
| title_full_unstemmed | Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market |
| title_short | Intellectual Property Related Generic Defense Strategies in the European Pharmaceutical Market |
| title_sort | intellectual property related generic defense strategies in the european pharmaceutical market |
| topic | K1-7720 Wettbewerbsrecht Handels- und Wirtschaftsrecht Kartellrecht bic Book Industry Communication::L Law |
| topic_facet | K1-7720 Wettbewerbsrecht Handels- und Wirtschaftsrecht Kartellrecht bic Book Industry Communication::L Law |
| url | 29431 |
| work_keys_str_mv | AT philippmarcp intellectualpropertyrelatedgenericdefensestrategiesintheeuropeanpharmaceuticalmarket |